Annual Total Liabilities
$15.77 M
-$109.04 M-87.36%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual total liabilities is $15.77 million, with the most recent change of -$109.04 million (-87.36%) on December 31, 2023.
- During the last 3 years, ELTX annual total liabilities has fallen by -$53.03 million (-77.07%).
- ELTX annual total liabilities is now -87.36% below its all-time high of $124.81 million, reached on December 31, 2022.
Performance
ELTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$57.37 M
+$39.97 M+229.70%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly total liabilities is $57.37 million, with the most recent change of +$39.97 million (+229.70%) on September 30, 2024.
- Over the past year, ELTX quarterly total liabilities has increased by +$39.67 million (+224.13%).
- ELTX quarterly total liabilities is now -54.03% below its all-time high of $124.81 million, reached on December 31, 2022.
Performance
ELTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ELTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.4% | +224.1% |
| 3 y3 years | -77.1% | - |
| 5 y5 years | -63.9% | - |
ELTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.4% | at low | -54.0% | +308.0% |
| 5 y | 5-year | -87.4% | at low | -54.0% | +308.0% |
| alltime | all time | -87.4% | at low | -54.0% | +308.0% |
Elicio Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $57.37 M(+229.7%) |
| Jun 2024 | - | $17.40 M(-11.3%) |
| Mar 2024 | - | $19.61 M(+24.3%) |
| Dec 2023 | $15.77 M | $15.77 M(-10.9%) |
| Sep 2023 | - | $17.70 M(+25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $14.06 M(-88.7%) |
| Dec 2022 | $124.81 M(+39.7%) | $124.81 M(+68.7%) |
| Dec 2021 | $89.35 M(+29.9%) | - |
| Mar 2021 | - | $73.99 M |
| Dec 2020 | $68.80 M(+57.3%) | - |
| Dec 2019 | $43.73 M | - |
FAQ
- What is Elicio Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Elicio Therapeutics?
- What is Elicio Therapeutics annual total liabilities year-on-year change?
- What is Elicio Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly total liabilities year-on-year change?
What is Elicio Therapeutics annual total liabilities?
The current annual total liabilities of ELTX is $15.77 M
What is the all time high annual total liabilities for Elicio Therapeutics?
Elicio Therapeutics all-time high annual total liabilities is $124.81 M
What is Elicio Therapeutics annual total liabilities year-on-year change?
Over the past year, ELTX annual total liabilities has changed by -$109.04 M (-87.36%)
What is Elicio Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ELTX is $57.37 M
What is the all time high quarterly total liabilities for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly total liabilities is $124.81 M
What is Elicio Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ELTX quarterly total liabilities has changed by +$39.67 M (+224.13%)